Products for Research Use Only
RegisterLogin

C9-200

CAT: 0804-HY-172335Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-172335Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
C9-200 is an ionizable cationic lipid that has been used in the formation of lipid nanoparticles (LNPs) . C9-200-based LNPs encapsulating mRNA encoding erythropoietin (EPO) can induced EPO production and stimulate red blood cell production in mice[1].
UNSPSC
12352211
Target
Liposome
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Others
Smiles
CCCCCCCC(O)CN(CCN1CCN(CCN(CC(O)CCCCCCC)CC(O)CCCCCCC)CC1)CCN(CC(O)CCCCCCC)CC(O)CCCCCCC
Molecular Formula
C55H115N5O5
Molecular Weight
926.53
References & Citations
[1]Mrksich K, et al. Influence of ionizable lipid tail length on lipid nanoparticle delivery of mRNA of varying length. J Biomed Mater Res A. 2024 Sep;112 (9) :1494-1505.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported

Related Products

CatalogName
HY-138527-01Thiol-C9-PEG4
HY-138529Thiol-C9-PEG5
HY-171836C9, t11-CLA
HY-W140827Boc-C9-Br
HY-176905Tacedinaline-C9-acid
HY-175887Pomalidomide-C9-Br
HY-138517-01Thiol-C9-PEG7
HY-W108995Boc-C9-COOH
HY-138526Thiol-C9-PEG4-acid
HY-153371-0150-C2-C9-4tail

Alternative Products

CatalogName
T203720-01C9-200
298043C9 (Complement Component C9)
H7023-27YHox C9 (Homeobox C9)
F43252-0.4MLC9 Antibody / Complement C9
TS404712P5Complement C9 (C9) CytoSection
CSB-CL004259HUC9
308606-01C9 (Complement C9, Complement Component C9, C9D, ARMD15)
C7850-53CC9 (Complement Component C9) discontinued
abx377239-01Complement Component C9 (C9) Antibody
221229-01C9 (Complement Component C9, Complement Component C9a, C9) discontinued

Popular Products